ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 105 filers reported holding ARATANA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $519,000 | +119.9% | 100,644 | +53.5% | 0.00% | – |
| Q1 2019 | $236,000 | -70.5% | 65,574 | -49.7% | 0.00% | -100.0% |
| Q4 2018 | $799,000 | +71.8% | 130,395 | +63.6% | 0.00% | – |
| Q3 2018 | $465,000 | +72.9% | 79,692 | +26.1% | 0.00% | – |
| Q2 2018 | $269,000 | +17.0% | 63,204 | +21.0% | 0.00% | – |
| Q1 2018 | $230,000 | +14.4% | 52,237 | +36.4% | 0.00% | – |
| Q4 2017 | $201,000 | +5.8% | 38,296 | +23.6% | 0.00% | – |
| Q3 2017 | $190,000 | -12.8% | 30,985 | +2.8% | 0.00% | – |
| Q2 2017 | $218,000 | +45.3% | 30,127 | +6.6% | 0.00% | – |
| Q1 2017 | $150,000 | -26.8% | 28,252 | -0.9% | 0.00% | – |
| Q4 2016 | $205,000 | -49.4% | 28,509 | -34.2% | 0.00% | -100.0% |
| Q3 2016 | $405,000 | +128.8% | 43,307 | +54.9% | 0.00% | – |
| Q2 2016 | $177,000 | +34.1% | 27,958 | +16.6% | 0.00% | – |
| Q1 2016 | $132,000 | -62.6% | 23,969 | -62.1% | 0.00% | -100.0% |
| Q4 2015 | $353,000 | – | 63,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
| Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
| Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
| CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
| Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
| Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
| MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
| Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |